Coeliac disease: complications and comorbidities
- PMID: 39875649
- DOI: 10.1038/s41575-024-01032-w
Coeliac disease: complications and comorbidities
Abstract
Coeliac disease is an autoimmune disease characterized by small intestinal villus atrophy and inflammation upon exposure to gluten. It has a global prevalence of approximately 1%. Although the gluten-free diet can be an effective treatment, this diet is burdensome with practical difficulties and frequent inadvertent gluten exposure. Moreover, there are a variety of potential complications and comorbidities of coeliac disease that might be related to malabsorption and/or chronic immune activation. Overall, individuals with coeliac disease have increased mortality compared with the general population, underscoring the severity of this common disease. Comorbidities and complications that have been associated with coeliac disease include poor growth, reproductive complications, kidney and liver diseases, respiratory disease (such as pneumonia) and infections (including sepsis). Furthermore, coeliac disease has been linked to other autoimmune disease and psychiatric disease, as well as certain cancers. Data suggest that mucosal healing on a gluten-free diet might protect against some, but not all, of these complications. In this Review, we present absolute and relative risks of coeliac-associated disorders. We discuss underlying mechanisms, the role of the gluten-free diet and mucosal healing, as well as implications for follow-up and non-dietary treatment of coeliac disease.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: J.F.L. has coordinated an unrelated study on behalf of the Swedish Inflammatory Bowel Disease quality register (SWIBREG). That study received funding from the Janssen Corporation. J.F.L. has also received financial support from Merck Sharp & Dohme to develop a paper reviewing national healthcare registers in China. J.F.L. also has a research collaboration on coeliac disease with Takeda. D.A.L. receives a salary as an employee of Takeda Pharmaceuticals.
References
-
- Al-Toma, A. et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. U Eur. Gastroenterol. J. 7, 583–613 (2019). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
